Search
for
Sort by
Research 571–600 of 1000+
- Direct Vasodilators and Sympatholytic Agents
- Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma
- Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity
- New oral anticoagulants and their reversal agents
- Nitroxide pharmaceutical development for age-related degeneration and disease
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Nivolumab-Induced Alopecia Areata: A Case Report and Literature Review
- Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis
- Preclinical Development and Phase I Study of ZSYY001, a Polymeric Micellar Paclitaxel for Advanced Solid Tumor
- A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial
- The Effects of Lower vs Higher Cell Number of Platelet-Rich Plasma (PRP) on Hair Density and Diameter in Androgenetic Alopecia (AGA): A Randomized, Double-Blinded, Placebo, Parallel-Group Half-Scalp IRB-Approved Study.
- Pericardial, pleural effusion and anasarca: A rare complication of low-dose oral minoxidil for hair loss
- Case 2-2022: An Adolescent Male in Cardiac Arrest 3 Days After Liver Transplantation for End-Stage Liver Disease
- Role of Extracellular Vesicles as Mediators of Cell Communication and Novel Biomarkers in Sepsis
- Essential Oils and Melatonin as Functional Ingredients in Dogs
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- MULTISYSTEM ADVERSE EFFECTS OF ISOTRETINOIN: MECHANISTIC INSIGHTS AND CLINICAL IMPLICATIONS
- Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis
- Microbial allies in skin trauma recovery: from immune modulation to engineered probiotic therapeutics
- The safety and efficacy of finasteride for transgender men with androgenetic alopecia: a case series
- BH06 (P075) A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata
- P075 A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- Toxic and Metabolic Disorders of the Nervous System
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- Evidence based medicine: a movement in crisis?
- Cutaneous wound healing: recruiting developmental pathways for regeneration
- Mesotherapy: From Historical Notes to Scientific Evidence and Future Prospects